Scholar Rock Holding Corp - COMMON STOCK (SRRK) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
SRRK on Nasdaq
Shares outstanding
95,602,778
Price per share
$44.05
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
116,003,215
Total reported value
$4,320,303,918
% of total 13F portfolios
0.01%
Share change
+6,077,555
Value change
+$233,674,748
Number of holders
238
Price from insider filings
$44.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Scholar Rock Holding Corp - COMMON STOCK (SRRK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $381,925,625 14,114,029 FMR LLC 31 Dec 2024
Invus Global Management, LLC 11% $292,924,852 10,825,013 Invus Public Equities, L.P. 31 Dec 2024
Redmile Group, LLC 9.9% $267,491,455 9,885,124 Redmile Group, LLC 31 Dec 2024
Samsara BioCapital, L.P. 7.2% $260,368,230 6,991,553 Srinivas Akkaraju 03 Oct 2025
PRICE T ROWE ASSOCIATES INC /MD/ 7.2% -22% $256,337,816 -$69,951,020 6,883,400 -21% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 30 Sep 2025, 238 institutional investors reported holding 116,003,215 shares of Scholar Rock Holding Corp - COMMON STOCK (SRRK). This represents 121% of the company’s total 95,602,778 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Scholar Rock Holding Corp - COMMON STOCK (SRRK) together control 95% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 14,012,078 +1.3% 0.03% $521,809,784
Siren, L.L.C. 9.7% 9,250,005 0% 13% $344,470,186
PRICE T ROWE ASSOCIATES INC /MD/ 7.2% 6,883,058 -21% 0.03% $256,326,000
BlackRock, Inc. 7.1% 6,760,187 +0.96% 0% $251,749,365
SAMSARA BIOCAPITAL, LLC 5.9% 5,612,896 0% 27% $209,024,247
VANGUARD GROUP INC 5.1% 4,914,927 +1.1% 0% $183,031,882
WELLINGTON MANAGEMENT GROUP LLP 4.8% 4,545,887 +125% 0.03% $169,288,833
Redmile Group, LLC 4.1% 3,904,456 -0.63% 14% $145,401,941
STATE STREET CORP 3.9% 3,763,103 +22% 0% $140,137,956
Bellevue Group AG 3.4% 3,244,537 +10% 2.5% $120,826,557
JANUS HENDERSON GROUP PLC 3.2% 3,013,445 +23% 0.05% $112,166,119
EVENTIDE ASSET MANAGEMENT, LLC 2.9% 2,799,456 -3.9% 1.7% $104,265,911
Holocene Advisors, LP 2.6% 2,461,596 0.21% $91,669,835
Driehaus Capital Management LLC 2.1% 2,023,959 +72% 0.54% $75,372,233
Hood River Capital Management LLC 2.1% 2,014,393 +2% 0.89% $75,015,995
Paradigm Biocapital Advisors LP 2.1% 2,009,745 +26% 2.2% $74,842,904
GEODE CAPITAL MANAGEMENT, LLC 2% 1,954,810 +3.6% 0% $72,808,689
ADAGE CAPITAL PARTNERS GP, L.L.C. 2% 1,951,866 +61% 0.12% $72,687,490
Fairmount Funds Management LLC 1.9% 1,824,031 0% 6.1% $67,926,914
JENNISON ASSOCIATES LLC 1.7% 1,606,512 +339% 0.03% $59,826,508
GOLDMAN SACHS GROUP INC 1.6% 1,563,089 +21% 0.01% $58,209,435
Vestal Point Capital, LP 1.6% 1,500,000 0% 2.5% $55,860,000
Pictet Asset Management Holding SA 1.4% 1,322,931 +34% 0.05% $49,265,950
RA CAPITAL MANAGEMENT, L.P. 1.2% 1,166,788 +2.7% 0.54% $43,451,185
UBS Group AG 1.2% 1,131,787 +234% 0.01% $42,147,747

Institutional Holders of Scholar Rock Holding Corp - COMMON STOCK (SRRK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,990,981 $528,081,242 +$69,369,001 $44.05 81
2025 Q3 116,003,215 $4,320,303,918 +$233,674,748 $37.24 238
2025 Q2 109,769,887 $3,888,022,565 +$178,857,647 $35.42 232
2025 Q1 104,837,027 $3,371,744,385 -$33,211,009 $32.15 229
2024 Q4 104,353,890 $4,510,154,046 +$795,913,914 $43.22 222
2024 Q3 86,874,031 $696,347,614 -$87,160,656 $8.01 162
2024 Q2 84,909,635 $707,292,187 -$4,836,436 $8.33 162
2024 Q1 84,762,558 $1,505,323,312 +$74,283,196 $17.76 158
2023 Q4 414,577 $7,794,047 +$6,922,593 $18.80 2
2023 Q3 53,866,733 $382,455,780 +$18,450,990 $7.10 87
2023 Q2 51,200,129 $386,065,257 +$33,069,958 $7.54 82
2023 Q1 46,750,715 $373,999,399 +$11,075,211 $8.00 84
2022 Q4 45,316,811 $410,005,498 +$2,413,606 $9.05 80
2022 Q3 43,442,911 $301,110,444 -$17,846,046 $6.93 78
2022 Q2 44,895,100 $246,462,110 +$52,975,380 $5.49 76
2022 Q1 31,126,848 $401,143,995 +$14,954,975 $12.89 90
2021 Q4 29,715,608 $738,181,500 +$15,736,114 $24.84 86
2021 Q3 28,775,783 $950,137,844 +$12,240,699 $33.02 98
2021 Q2 28,210,930 $815,519,276 -$12,012,659 $28.90 101
2021 Q1 27,784,333 $1,407,469,072 +$56,832,605 $50.66 119
2020 Q4 24,691,360 $1,198,238,471 +$289,314,078 $48.53 107
2020 Q3 21,238,414 $375,758,713 +$18,169,858 $17.69 68
2020 Q2 20,200,115 $367,835,744 +$19,849,055 $18.21 65
2020 Q1 19,179,659 $232,274,834 +$5,738,428 $12.11 60
2019 Q4 18,641,494 $245,693,414 +$8,763,392 $13.18 53
2019 Q3 18,083,537 $161,854,847 -$1,744,371 $8.95 54
2019 Q2 17,764,463 $281,612,575 +$84,891,360 $15.86 62
2019 Q1 14,085,067 $264,650,687 +$12,137,445 $18.79 42
2018 Q4 13,387,334 $307,505,000 +$6,425,595 $22.97 39
2018 Q3 13,104,137 $333,760,000 +$20,121,088 $25.75 37
2018 Q2 12,530,479 $189,992,058 +$189,992,327 $15.60 28